Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?

about

Silodosin : a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.Does Baseline Prostate Volume Affect the Short-Term Outcome of Tamsulosin?

P2860

Q38038271-9B1F1DF1-C7C6-42D5-882F-A3D5491D9460 Q40215585-EE3D8A21-F8E1-4BE0-B06F-9270D3DA7EBE

P2860

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?

Item

http://www.wikidata.org/entity/Q41770323

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Effect of estimated prostate v ...... PH: does prostate size matter?

@en

type

Item

label

Effect of estimated prostate v ...... PH: does prostate size matter?

@en

prefLabel

Effect of estimated prostate v ...... PH: does prostate size matter?

@en

P1476

Effect of estimated prostate v ...... PH: does prostate size matter?

@en

P2093

Claus G Roehrborn

http://www.w3.org/2001/XMLSchema#string

Lawrence A Hill

http://www.w3.org/2001/XMLSchema#string

Steven A Kaplan

http://www.w3.org/2001/XMLSchema#string

Weining Volinn

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.

KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

Alpha blockers for the treatment of benign prostatic hyperplasia.

Alpha1-adrenoceptor subtypes and lower urinary tract symptoms

Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.

KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.

Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.

Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

P304

89-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OAJU.S18941

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258337436

http://www.w3.org/2001/XMLSchema#string

P698

24198640

http://www.w3.org/2001/XMLSchema#string

P932

3818948

http://www.w3.org/2001/XMLSchema#string

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?

about

P2860

P2860

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932